Oncology Medications

ALUNBRIG®
(brigatinib)

Alunbrig (brigatinib) now available from Onco360!

ALUNBRIG® is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.

Dosage and Administration

The recommended dosage for ALUNBRIG is 90 mg orally once daily for the first 7 days; then increase to 180 mg orally once daily. May be taken with or without food.

Dosage Forms and Strengths

 

For more information, visit Alunbrig.com 

How to Order

Call

Call 877-662-6633.

Fax

Download the Oral Rx
Oncology Order Form and
fax it to 877-662-6355.
Oral Order Form

e-Prescribe

e-Prescribe to Onco360 in Louisville, KY 40223, or NPI# 1437577988 under the retail tab in your EMR/EHR or standalone e-prescribing application.